Audience

What’s on for Therapeutic Developers:

  • Panel: Why Europe for ATMPS? Collaboration, Diversification and Leading the Charge for Cell and Gene Therapies
  • Debate: Facilitating Equity & Access for Global Cell and Gene Therapy Patients: How Do We Get There From Here
  • Session: Optimising Business Models for Emerging Biotech
  • Session: Transforming the ATMP Value Chain: The Power of Digitalisation in Cell and Gene Therapy
  • Session: Accelerating Cell and Gene Therapy Innovation: Regulatory Pathways in Europe

What’s on for Academics & Healthcare:

  • Track: Developing ATMPs Track 
  • Exhibition: Innovation Zone
  • Debate: Facilitating Equity & Access for Global Cell and Gene Therapy Patients: How Do We Get There From Here
  • Session: Ensuring Speed, Safety, and Supply in Delivering Therapies to Patients
  • Session: Accelerating Cell and Gene Therapy Innovation: Regulatory Pathways in Europe

What’s on for Start-ups:

  • Exhibition: Innovation Zone 
  • Track: Commercialising Future Therapies
  • Session: Optimising Business Models for Emerging Biotech

What’s on for Manufacturers:

  • Track: Commercialising Future Therapies Track 
  • Track: Technical Excellence Track 
  • Session: Scaling Up: Manufacturing Strategies for Commercial Success in Cell and Gene Therapy
  • Session: Building Essential Manufacturing Competencies for ATMPs from the Outset